Sagittarius Life Science Corp reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 114.57 million compared to TWD 134.51 million a year ago. Net loss was TWD 11.49 million compared to TWD 23.85 million a year ago. Basic loss per share from continuing operations was TWD 0.35 compared to TWD 0.73 a year ago. Diluted loss per share from continuing operations was TWD 0.35 compared to TWD 0.73 a year ago.
For the six months, sales was TWD 229.14 million compared to TWD 268.86 million a year ago. Net loss was TWD 25.49 million compared to TWD 45.16 million a year ago. Basic loss per share from continuing operations was TWD 0.78 compared to TWD 1.39 a year ago. Diluted loss per share from continuing operations was TWD 0.78 compared to TWD 1.39 a year ago.